Archives of Toxicology

, Volume 78, Issue 7, pp 402–409 | Cite as

Changes in the glutathione system of lung cell lines after treatment with hydrocortisone

Molecular Toxicology

Abstract

Administration of anti-inflammatory glucocorticoids is a drug option in the therapy of acute respiratory distress syndrome (ARDS), according to present pathophysiological concepts. Surprisingly, glucocorticoids failed to show beneficial effects. This failure is not understood. In this investigation changes in the glutathione system due to hydrocortisone were found to consist of glutathione depletion and lowered glutathione reductase activities in alveolar epithelial type II cells, contrasted with unchanged activities in a fibroblast-like lung cell line. The glutathione system is thought to be the most important cellular antioxidative system and therefore alveolar epithelial type II cells might be more susceptible to oxidative stress after glucocorticoid treatment. As alveolar epithelial type II cells may be important targets in ARDS, because of their functions (stem cells of type I epithelial cells; surfactant synthesis), these changes might provide an explanation for the failure of glucocorticoids. In the present experiments the capability of hydrocortisone-treated alveolar epithelial type II cells to synthesise glutathione was found to be cysteine dependent at physiological concentrations. Transposing this observation to the in vivo situation, it might be expected that glucocorticoid efficacy in ARDS therapy requires co-administration of substances that increase glutathione synthesis, e.g. N-acetylcysteine.

Keywords

Glucocorticoids Lung fibroblasts Alveolar epithelial type II cells ARDS 

References

  1. Ammon HPT, Müller PH, Eggstein M, Wintermantel C, Aigner B, Safayhi H, Stutzle M, Renn W (1992) Increase in glucose consumption by acetylcysteine during hyperglycemic clamp. A study with healthy volunteers. Drug Res 42:642–645Google Scholar
  2. Baritussio A, Pettenazzo A, Benevento M, Alberti A, Gamba P (1992) Surfactant protein C is recycled from the alveoli to the lamellar bodies. Am J Physiol 263:L607–L611PubMedGoogle Scholar
  3. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA, Harris TR, Brigham KL (1987) High-dose corticoids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565–1570PubMedGoogle Scholar
  4. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, Wright PE, and the Antioxidant in ARDS Study Group (1997) A trial of antioxidants N-acetylcysteine and procysteine in ARDS. Chest 112:164–172PubMedGoogle Scholar
  5. Bone R, Fisher C, Clemmer T, and the Methylprednisolone Severe Sepsis Study Group (1989) Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 92:1032–1036Google Scholar
  6. Bunnell E, Pacht ER (1993) Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 148:1174–1178PubMedGoogle Scholar
  7. Burgunder JM, Varriale A, Lauterburg BH (1989) Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol 36:127–131PubMedGoogle Scholar
  8. Cai J, Sun WM, Lu SC (1995) Hormonal and cell density regulation of hepatic γ-glutamylcysteine synthetase gene expression. Mol Pharmacol 48:212–218PubMedGoogle Scholar
  9. Cai J, Huang ZZ, Lu SC (1997) Differential regulation of γ-glutamycysteine synthetase heavy and light subunit gene expression. Biochem J 326:167–172PubMedGoogle Scholar
  10. Chobert MN, Grondin G, Brouillet A, Laperche Y, Beaudoin AR (1996) Control of γ-glutamyl transpeptidase expression by glucocorticoids in the rat pancreas. J Biol Chem 271:12431–12437CrossRefPubMedGoogle Scholar
  11. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER (1982) Cell number and cell characteristics of normal human lung. Am Rev Respir Dis 125:740–745PubMedGoogle Scholar
  12. Domenighetti G, Quattropani, C Schaller MD (1999) N-acetylcysteine and acute lung injury. Rev Mal Respir 16:29–37PubMedGoogle Scholar
  13. Goldberg DM, Spooner RJ (1987) Glutathione reductase. NAD(P)H: oxidized glutathione oxidoreductase (EC 1.6.4.2). In: Bergmeyer HU, Bergmeyer J, Grassl M (eds) Methods of enzymatic analysis, vol III, VCH, Weinheim, pp258–265Google Scholar
  14. Helm KU, Renovanz H-D, Schmahl K, v Clarmann M (1971) Die Zinknebelvergiftung und ihre Behandlung. I. Chemische und toxikologische Grundlagen. Wehrmed Monatsschrift 15:1–6Google Scholar
  15. Hjortsø E, Qvist J, Bud MI, Thomsen JL, Andersen JB, Wiberg-Jørgensen F, Jensen NK, Jones R, Reid MM, Zapol WM (1988) ARDS after accidental inhalation of zinc chloride smoke. Intensive Care Med 14:17–24PubMedGoogle Scholar
  16. Huang CS, Anderson ME, Meister A (1993) Amino acid sequence and function of the light subunit of rat kidney γ-glutamylcysteine synthetase. J Biol Chem 268:20578–20583PubMedGoogle Scholar
  17. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO (1992) Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med 20:918–923PubMedGoogle Scholar
  18. Laurent T, Markert M, Feihl F, Schaller MD, Perret C (1996) Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine. Chest 109:163–166PubMedGoogle Scholar
  19. Lee JW, Iwatsuru M, Nishigori H (1998) Alteration of activities of hepatic antioxidant defence enzymes in developing chick embryos after glucocorticoid administration—a factor to produce some adverse effects? J Pharm Pharmacol 50:655–660PubMedGoogle Scholar
  20. Lu SC, Ge JL, Kuhlenkamp, J Kaplowitz N (1992) Insulin and glucocorticoid dependence of hepatic γ-glutamylcysteine synthetase and glutathione synthesis in the rat. Studies in cultured hepatocytes and in vivo. J Clin Invest 90:524–532PubMedGoogle Scholar
  21. Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Forstell CG, Bonde J, and the ARF Study Group (1999) Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark and Iceland. Am J Respir Crit Care Med 159:1849–1861PubMedGoogle Scholar
  22. Meduri GU, Kanangat S (1998) Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: time for a critical reappraisal. Crit Care Med 26:630–633CrossRefPubMedGoogle Scholar
  23. Millar BC, Jinks S (1985) Studies on the relationship between the radiation resistance and glutathione content of human and rodent cells after treatment with dexamethasone in-vitro. Int J Rad Biol 47:539–552Google Scholar
  24. Mize CE, Langdon RG (1962) Hepatic glutathione reductase. J Biol Chem 237:1589–1595Google Scholar
  25. Moss M, Guidot DM, Wong LM, Hoor TT, Perez RL, Brown LAS (2000) The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med 161:414–419PubMedGoogle Scholar
  26. Ortolani O, Conti A, DeGaudio AR, Masoni M, Novelli G (2000) Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock 13:14–18PubMedGoogle Scholar
  27. Rahman I, Antonicelli F, MacNee W (1999) Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-α and dexamethasone in human alveolar epithelial cells. J Biol Chem 274:5088–5096CrossRefPubMedGoogle Scholar
  28. Read SM, Northcote DH (1981) Minimization of variation in the response to different proteins of the Coomassie Blue G dye-binding assay for protein. Anal Biochem 116:53–64PubMedGoogle Scholar
  29. Reed DJ (1990) Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 30:603–631Google Scholar
  30. Setogawa T, Kosano H, Ogihara-Umeda I, Kayanuma T, Nishigori H (1994) Preventive effect of SA3443, a novel cyclic disulfide, on glucocorticoid-induced cataract formation of developing chick embryo. Exp Eye Res 58:689–695CrossRefPubMedGoogle Scholar
  31. Steinebach OM, Wolterbeek HT (1993) Effects of zinc on rat hepatoma HTC cells and primary cultured rat hepatocytes. Toxicol Appl Pharmacol 118:245–254CrossRefPubMedGoogle Scholar
  32. Suter PM, Domenighetti G, Schaller MD, Laverriere MC, Ritz R, Perret C (1994) N-Acetylcysteine enhances recovery from acute lung injury in man: a randomized, double-blind, placebo-controlled clinical study. Chest 105:190–194PubMedGoogle Scholar
  33. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522PubMedGoogle Scholar
  34. Walmrath D, Guenther A, Grimminger F, Seeger W (2000) The alveolar surfactant system, it’s pathogenetic significance in acute lung failure (ARDS) and therapeutic perspectives. Intensivmed Notfallmed 37:307–317CrossRefGoogle Scholar
  35. Walther UI, Mückter H, Fichtl B, Forth W (1999a) Effect of hydrocortisone pretreatment on decreased protein synthesis in various lung cells after zinc chloride incubation. In Vitro Mol Toxicol 12: 109–117Google Scholar
  36. Walther UI, Mückter H, Fichtl B, Forth W (1999b) Influence of glutathione on zinc-mediated cellular toxicity. Biol Trace Elem Res 67:97–107PubMedGoogle Scholar
  37. Walther UI, Wilhelm B, Walther SC, Mückter H, Fichtl B (2000) Zinc toxicity in various lung cell lines is mediated by glutathione and GSSG reductase activity. Biol Trace Elem Res 78:163–177PubMedGoogle Scholar
  38. Wolff JEA, Denecke J, Jürgens H (1996) Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. Anticancer Res 16:805–810PubMedGoogle Scholar
  39. Zimmerman GA, Albertine KH, Carveth HJ, Gill EA, Grissom CK, Hoidal JR, Imaizumi T, Maloney CG, MacIntyre TM, Michael JR, Orme JF, Prescott SM, Topham MS (1999) Endothelial activation in ARDS. Chest 116:18S–24SCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Walther Straub-Institut für Pharmakologie und ToxikologieLudwig-Maximilians Universität MünchenMünchenGermany

Personalised recommendations